Steroids and Methotrexate to Treat Systemic Vasculitis
- Conditions
- InflammationVasculitisWegener's Granulomatosis
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 100
- Registration Number
- NCT00001256
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Genetically Modified Lymphocytes to Treat HIV-Infected Identical Twins - Study Modifications
- Conditions
- Acquired Immunodeficiency SyndromeHIV Infection
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 100
- Registration Number
- NCT00001409
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Interleukin-12 in the Treatment of Severe Nontuberculous Mycobacterial Infections
- Conditions
- Atypical Mycobacterium Infection
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 10
- Registration Number
- NCT00001911
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Interferon Gamma for Drug Resistant Tuberculosis
- Conditions
- PneumoniaPulmonary Tuberculosis
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 30
- Registration Number
- NCT00001407
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Interferon Gamma to Treat Leukocyte Adhesion Deficiency Type I
- Conditions
- Leukocyte Adhesion Deficiency Syndrome
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 5
- Registration Number
- NCT00001905
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Study of Immune Responses and Safety of Recombinant Human CD40 Ligand in Patients With X-Linked Hyper-IgM Syndrome
- Conditions
- Immunoproliferative Disorder
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 5
- Registration Number
- NCT00001145
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Characteristics of Mast Cells in Mastocytosis
- Conditions
- Mastocytosis
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 300
- Registration Number
- NCT00001356
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
White Blood Cell Infusions to Treat HIV Infection
- Conditions
- Acquired Immunodeficiency SyndromeHIV Infection
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 30
- Registration Number
- NCT00001647
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Interleukin-2 Therapy for HIV Infection - Supplemental Procedures
- Conditions
- Acquired Immunodeficiency SyndromeHIV Infection
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 60
- Registration Number
- NCT00001354
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States
Safety and Survival of Genetically Modified White Blood Cells in HIV-Infected Persons - A Study in Identical Twin Pairs
- Conditions
- Acquired Immunodeficiency SyndromeHIV Infection
- First Posted Date
- 1999-11-04
- Last Posted Date
- 2008-03-04
- Target Recruit Count
- 24
- Registration Number
- NCT00001353
- Locations
- ๐บ๐ธ
National Institute of Allergy and Infectious Diseases (NIAID), Bethesda, Maryland, United States